Incidence and Progression of Echocardiographic Abnormalities in Older Children with Human Immunodeficiency Virus and Adolescents Taking Antiretroviral Therapy: A Prospective Cohort Study.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
17 03 2020
Historique:
received: 28 02 2019
accepted: 02 05 2019
pubmed: 6 5 2019
medline: 7 1 2021
entrez: 5 5 2019
Statut: ppublish

Résumé

A high prevalence of cardiac abnormalities has been reported in children with human immunodeficiency virus (HIV) taking antiretroviral therapy (ART) in sub-Saharan Africa. We investigated the incidence and progression of cardiac abnormalities among children taking ART in Zimbabwe. A prospective cohort study was conducted at a pediatric HIV clinic from 2014 to 2017. Children with HIV aged between 6 and 16 years and taking ART ≥6 months were enrolled. Transthoracic echocardiography was performed at baseline and after 18 months. Of 197 participants recruited at baseline, 175 (89%; 48% female; median age 12 years, interquartile range 10-14 years) were followed up. The incidences of left and right heart abnormalities were 3.52 and 5.64 per 100 person-years, respectively. Stunting was associated with the development of any cardiac abnormality (adjusted odds ratio 2.59, 95% confidence interval 1.03-6.49; P = .043). Right ventricular (RV) dilatation persisted at follow-up in 92% of participants and left ventricular (LV) diastolic dysfunction in 88%. Cardiac abnormalities present at baseline reverted to normal over the follow-up period in 11 (6%). There was an overall increase in mean z scores for LV, left atrium (LA), RV, interventricular septum, and LV posterior wall diameters at 18 months (P < .001). Despite ART, children with HIV have a high incidence of cardiac abnormalities, with only a minority being transient. Mean z scores for LV, LA, RV, interventricular septum, and LV posterior wall diameters increased over a relatively short follow-up period, suggesting the potential for progression of cardiac abnormalities. Longer follow-up is required to understand the clinical implications of these abnormalities.

Sections du résumé

BACKGROUND
A high prevalence of cardiac abnormalities has been reported in children with human immunodeficiency virus (HIV) taking antiretroviral therapy (ART) in sub-Saharan Africa. We investigated the incidence and progression of cardiac abnormalities among children taking ART in Zimbabwe.
METHODS
A prospective cohort study was conducted at a pediatric HIV clinic from 2014 to 2017. Children with HIV aged between 6 and 16 years and taking ART ≥6 months were enrolled. Transthoracic echocardiography was performed at baseline and after 18 months.
RESULTS
Of 197 participants recruited at baseline, 175 (89%; 48% female; median age 12 years, interquartile range 10-14 years) were followed up. The incidences of left and right heart abnormalities were 3.52 and 5.64 per 100 person-years, respectively. Stunting was associated with the development of any cardiac abnormality (adjusted odds ratio 2.59, 95% confidence interval 1.03-6.49; P = .043). Right ventricular (RV) dilatation persisted at follow-up in 92% of participants and left ventricular (LV) diastolic dysfunction in 88%. Cardiac abnormalities present at baseline reverted to normal over the follow-up period in 11 (6%). There was an overall increase in mean z scores for LV, left atrium (LA), RV, interventricular septum, and LV posterior wall diameters at 18 months (P < .001).
CONCLUSIONS
Despite ART, children with HIV have a high incidence of cardiac abnormalities, with only a minority being transient. Mean z scores for LV, LA, RV, interventricular septum, and LV posterior wall diameters increased over a relatively short follow-up period, suggesting the potential for progression of cardiac abnormalities. Longer follow-up is required to understand the clinical implications of these abnormalities.

Identifiants

pubmed: 31054255
pii: 5485713
doi: 10.1093/cid/ciz373
pmc: PMC7931829
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1372-1378

Subventions

Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 095878/Z/11/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

BMJ. 1994 Dec 17;309(6969):1605-7
pubmed: 7819934
Curr Opin HIV AIDS. 2017 Nov;12(6):534-539
pubmed: 28863015
J Am Coll Cardiol. 1991 May;17(6):1270-6
pubmed: 1826690
AIDS. 2018 Nov 28;32(18):2739-2748
pubmed: 30289814
Am Heart J. 2005 Sep;150(3):439-47
pubmed: 16169321
Clin Infect Dis. 2013 Feb;56(4):576-82
pubmed: 23097588
Swiss Med Wkly. 2014 Oct 02;144:w14010
pubmed: 25275335
Int J Cardiol. 2017 Dec 1;248:409-413
pubmed: 28711335
J Pediatr. 2002 Sep;141(3):327-34
pubmed: 12219051
Cardiovasc Diagn Ther. 2015 Dec;5(6):444-53
pubmed: 26675054
Arch Dis Child. 1976 Mar;51(3):170-9
pubmed: 952550
PLoS One. 2014 Feb 18;9(2):e86928
pubmed: 24558364
Cardiol Clin. 2012 May;30(2):243-56
pubmed: 22548815
Am J Cardiol. 2016 Apr 1;117(7):1194-5
pubmed: 26993978
Antiviral Res. 2010 Jan;85(1):201-9
pubmed: 19857521
Jpn Circ J. 2001 Oct;65(10):863-6
pubmed: 11665789
Circulation. 1998 Apr 7;97(13):1246-56
pubmed: 9570194
HIV Med. 2010 Feb;11(2):130-6
pubmed: 19682101
PLoS One. 2012;7(12):e52856
pubmed: 23285204
AIDS. 2003 Apr;17 Suppl 1:S46-50
pubmed: 12870530
Clin Infect Dis. 2018 Jan 6;66(2):274-281
pubmed: 29020237
N Engl J Med. 2008 Nov 20;359(21):2233-44
pubmed: 19020325
Infect Dis Clin North Am. 2014 Sep;28(3):323-37
pubmed: 25151559
PLoS Med. 2018 Mar 1;15(3):e1002514
pubmed: 29494593
Circulation. 2014 Apr 29;129(17):1781-9
pubmed: 24778120
AIDS. 2012 Oct 23;26(16):2027-37
pubmed: 22781228
Lancet Infect Dis. 2014 Jul;14(7):627-39
pubmed: 24406145
AIDS. 2016 Nov 28;30(18):2795-2803
pubmed: 27662546
Pediatr Cardiol. 2018 Jun;39(5):859-868
pubmed: 29616292
South Med J. 2006 Mar;99(3):274-8
pubmed: 16553101
Curr Opin HIV AIDS. 2016 Mar;11(2):216-25
pubmed: 26599166
Clin Infect Dis. 2010 Oct 1;51(7):844-51
pubmed: 20804412
Clin Infect Dis. 2011 Feb 1;52(3):378-86
pubmed: 21217185
Circ Cardiovasc Imaging. 2016 Mar;9(3):e004430
pubmed: 26951605
Curr HIV/AIDS Rep. 2012 Jun;9(2):139-47
pubmed: 22528766

Auteurs

Edith D Majonga (ED)

London School of Hygiene and Tropical Medicine, United Kingdom.
Biomedical Research and Training Institute, Harare.

Andrea M Rehman (AM)

London School of Hygiene and Tropical Medicine, United Kingdom.

Grace Mchugh (G)

Biomedical Research and Training Institute, Harare.

Hilda A Mujuru (HA)

University of Zimbabwe, Harare.

Kusum Nathoo (K)

University of Zimbabwe, Harare.

Jon O Odland (JO)

The Norwegian University for Science and Technology, Trondheim.
Department of Public Health, University of Pretoria, South Africa.

Rashida A Ferrand (RA)

London School of Hygiene and Tropical Medicine, United Kingdom.
Biomedical Research and Training Institute, Harare.

Juan Pablo Kaski (JP)

Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital.
Institute of Cardiovascular Science, University College London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH